You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CGEM Award Disclosure
Fenton Mary Kay · SEC Form 4 · Filed Jul 2, 2026
Award
Calculated transaction value
$13.25K
Fenton Mary Kay Chief Financial Officer
CGEM
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
CGEM daily price context
Close on/before transaction
$18.21
Jun 30, 2026
First close after public filing
$17.81
Jul 6, 2026
30-day return after filing
-8.76%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,541 shares @ $8.6
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-294863
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$13.25K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cullinan Therapeutics, Inc. CGEM Current | Award | Jun 30, 2026 | $13.25K |